|Mean Daily Check-Ins||6.43 days per week|
|Mean Time on Site per Visit||2:03 minutes|
|Mean Time on Site per Month||60 minutes|
|Mean Days Engaged Per Year||329.4 days|
|Increase in Proportion of Days Covered (PDC)||↑ 44%||(P < 0.0001)|
|Likelihood to Be Fully Adherent to Treatment||2.51x||(P < 0.0001)|
|Lowered Risk of Discontinuing Index Treatment||↓ 47%||(P < 0.0001)|
|Additional Days On Therapy||↑ 82 Days||(P < 0.0001)|
|PDC After 12 Months Enrollment|
|Average PDC after 12 Months||90.1%|
|Percentage of Previously Nonadherent Members who Became Adherent after 12 Months||76.8%|
|Condition||Fill Lift||Data Source|
|Chronic Kidney Disease||↑ 50%||Internal|
1. 2023 Validation Report for HealthPrize. Validation Institute.
2. HealthPrize Member Registry. Data from all HealthPrize programs between January 2019 and May 2022.
3. Franchino-Elder J, Hayes V, Shaikh A, Firlik K. Assessment of medication adherence and the association with health care resource utilization and costs among HealthPrize-enrolled COPD patients, Presented at the American Thoracic Society 2022 International Conference.